^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Peripheral T-cell Lymphoma |
| Regimen: | ESHAP (cytarabine + etoposide IV + ) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Peripheral T-Cell Lymphomas...Other recommended regimens...ESHAP (etoposide, methylprednisolone, cytarabine) + platinum (cisplatin or oxaliplatin)
Secondary therapy:
oxaliplatin; cisplatin
